Data as of Aug 21
| -0.05 / -2.39%|
The 1 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +47.06% increase from the last price of 2.04.
The current consensus among 1 polled investment analysts is to Buy stock in CorMedix Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.